Shuang Liu

机构：Nanjing University of Chinese Medicine, Shaanxi University of Technology · ORCID：0000-0002-6647-6197

发表论文 39 篇 · 总被引 1210 次 · h-index 16

代表论文

• Gut microbiota alters host bile acid metabolism to contribute to intrahepatic cholestasis of pregnancy (2023 · Nature Communications · 被引 126)
• PARG inhibition limits HCC progression and potentiates the efficacy of immune checkpoint therapy (2022 · Journal of Hepatology · 被引 54)
• Targeting ABCB6 with nitidine chloride inhibits PI3K/AKT signaling pathway to promote ferroptosis in multiple myeloma (2023 · Free Radical Biology and Medicine · 被引 43)
• Ferroptosis and EMT resistance in cancer: a comprehensive review of the interplay (2024 · Frontiers in Oncology · 被引 30)
• Structure-Based Drug Design of 2-Amino-[1,1′-biphenyl]-3-carboxamide Derivatives as Selective PKMYT1 Inhibitors for the Treatment of CCNE1 -Amplified Breast Cancer (2024 · Journal of Medicinal Chemistry · 被引 19)
• Lactylation-driven MVP upregulation boosts immunotherapy resistance by inhibiting PD-L1 degradation in hepatocellular carcinoma (2025 · Journal for ImmunoTherapy of Cancer · 被引 15)